Next Generation FlexPen has been available in some countries from late 2008 but has been launched in India in this month. It has built upon the high standards set by FlexPen. This new FlexPen has 30% less force when injecting , so that it can be injected with just a gentle push. It has new coloured cartridge holders, labels and packaging to aid insulin type identification for patients. These features provide improved convenience and ease of use for people with diabetes.
"Patients with diabetes generally prefer an insulin device with a lower injection force because it causes less discomfort when injecting" said renowned endocrinologist Dr Bipin Sethi. Since patients with diabetes use this product on a regular basis they need to have a delivery system that is simple and easy to use. The next generation Flexpen would give them the confidence to use it on regular basis and comply with the insulin regimen prescribed by their doctor."
"The distinct color coding of the Next Generation FlexPen will be helpful for easy identification of the product, especially for elderly patients" said leading endocrinologist Dr. Sudhakar Rao.
Next Generation FlexPen is a result of more than 25 years of research and development of insulin delivery systems undertaken since Novo Nordisk invented the insulin pen. Compared to other insulin delivery devices that have to be manually loaded with insulin cartridges, prefilled pens are ready to use, eliminating the step of loading insulin cartridge into the delivery device. Next Generation FlexPen features a single-step dose-setting mechanism, portability and a discreet non-medical appearance.
Next Generation FlexPen like the previous FlexPen permits dose corrections without loss of insulin, and provides doses in one-unit increments up to 60 units per injection (each pen contains 300 units in total). The dose scale on Next Generation FlexPen automatically returns to zero after injection to allow visual confirmation of dose delivery.